¼¼°èÀÇ Ç×±Õ ¼ººÐ ½ÃÀå
Antimicrobial Ingredients
»óǰÄÚµå : 1655451
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 196 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,301,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,905,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ Ç×±Õ ¼ººÐ ½ÃÀåÀº 2030³â±îÁö 67¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 57¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ Ç×±Õ ¼ººÐ ½ÃÀåÀº 2024-2030³â¿¡ CAGR 2.6%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 67¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ Ç×±ÕÁ¦´Â CAGR 2.4%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 23¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Ç×Áø±ÕÁ¦ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 3.2%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 16¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 5.2%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Ç×±Õ ¼ººÐ ½ÃÀåÀº 2024³â¿¡ 16¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 13¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 5.2%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 0.7%¿Í 1.9%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 1.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Ç×±Õ ¼ººÐ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Ç×±Õ ¼ººÐÀÌ ¼ÒºñÀÚ Á¦Ç°¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® ÀâÀº ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

Ç×±Õ ¼ººÐ ¼¼°è ½ÃÀåÀº À§»ý¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í °Ç°­ ÁöÇâÀûÀÎ ¼ÒºñÀÚ ÇൿÀ¸·Î ÀÎÇØ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. À¯ÇØ ¹Ì»ý¹°ÀÇ Áõ½ÄÀ» ¾ïÁ¦ÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÌ ¼ººÐµéÀº ÆÛ½º³ÎÄɾî Á¦Ç°, ÀǾàǰ, ½Äǰ Æ÷Àå ¹× ÀÇ·á±â±â¿¡ ±¤¹üÀ§ÇÏ°Ô »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ã¤ÅÃÀº °¨¿°¼º Áúȯ¿¡ ´ëÇÑ ¿ì·Á¿Í Ç×±ÕÁ¦ ³»¼º ¹ÚÅ׸®¾ÆÀÇ ¹ß»ý·ü Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇÑ °ÍÀÔ´Ï´Ù. ƯÈ÷ ÇǺΠ°ü¸®, »óó °ü¸®, ½Äǰ ¾ÈÀü ºÐ¾ß¿¡¼­ Ç×±Õ È­ÇÕ¹°À» »ç¿ëÇÏ´Â Á¦Á¶¾÷üµéÀº ´õ ±ä À¯Åë±âÇÑ, ¾ÈÀü¼º, û°áÀ» ¾à¼ÓÇÏ´Â Á¦Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä·Î ÀÎÇØ Ç×±Õ È­ÇÕ¹° »ç¿ëÀ» ´Ã¸®°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÎ½Ä Áõ°¡´Â ¿¡¼¾¼È ¿ÀÀÏÀ̳ª ½Ä¹° ÃßÃâ¹°°ú °°ÀÌ ÇÕ¼º È­ÇÐ ¹°Áúº¸´Ù ¾ÈÀüÇÏ´Ù°í ÀνĵǴ õ¿¬ Ç×±Õ ¼ººÐ¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡¿¡µµ ¹Ý¿µµÇ°í ÀÖ½À´Ï´Ù.

±â¼úÀº Ç×±Õ ¼ººÐÀÇ ¹Ì·¡¸¦ ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

»ý¸í°øÇÐ ¹× Àç·á °úÇÐÀÇ ±â¼ú ¹ßÀüÀº Ç×±Õ ¼ººÐÀÇ »óȲÀ» ¿ÏÀüÈ÷ ¹Ù²Ù¾î ³õ¾Ò½À´Ï´Ù. ¿¹¸¦ µé¾î ³ª³ëÅ×Å©³î·¯ÁöÀº º¸´Ù È¿°úÀûÀÎ Ç×±Õ ÄÚÆÃÀ» °³¹ßÇÒ ¼ö ÀÖ°Ô Çß½À´Ï´Ù. ¿¹¸¦ µé¾î Àº ³ª³ëÀÔÀÚ´Â °­·ÂÇÑ Ç×±Õ Æ¯¼ºÀ¸·Î ÀÎÇØ ÇコÄÉ¾î ¹× ¼ÒºñÀÚ Á¦Ç°¿¡¼­ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. ÀÎĸ½¶·¹ÀÌ¼Ç ±â¼úÀÇ »ç¿ëÀº Ç×±ÕÁ¦ÀÇ È¿À²À» ³ôÀÌ°í »óó µå·¹½Ì ¹× ½Äǰ Æ÷Àå°ú °°Àº ¿ëµµ¿¡¼­ ¹æÃâÀ» Á¦¾îÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ¶ÇÇÑ ÇÕ¼º »ý¹°ÇÐÀÇ Çõ½ÅÀº À¯ÀÍÇÑ ¹Ì»ý¹°¿¡ ¿µÇâÀ» ¹ÌÄ¡Áö ¾Ê°í ƯÁ¤ º´¿ø±ÕÀ» ÁßÈ­ÇÒ ¼ö ÀÖ´Â °íµµ·Î Ç¥ÀûÈ­µÈ Ç×±Õ ÆéƼµå¿Í È¿¼Ò¸¦ °³¹ßÇÒ ¼ö ÀÖ°Ô Çß½À´Ï´Ù. ÀÌ·¯ÇÑ »õ·Î¿î ±â¼úÀÇ Á¶ÇÕÀº °¢ »ê¾÷ ºÐ¾ß¿¡¼­ º¸´Ù Àü¹®ÀûÀ̰í È¿°úÀûÀÎ Ç×±Õ ¼Ö·ç¼ÇÀÇ ±æÀ» ¿­¾îÁÖ°í ÀÖ½À´Ï´Ù.

ÀÌ È®´ëµÇ´Â ½ÃÀå¿¡¼­ ±ÔÁ¦ ±âÁØÀº ¾î¶² ¿ªÇÒÀ» Çϰí Àִ°¡?

±ÔÁ¦ ¹× Ç¥ÁØÀº ƯÈ÷ ÇコÄɾî, ½Äǰ ¹× È­Àåǰ »ê¾÷¿¡¼­ Ç×±Õ ¼ººÐ ½ÃÀå Çü¼º¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, FDA, À¯·´ÀǾàǰû(European Medicines Agency) ¹× EFSA¿Í °°Àº ±ÔÁ¦±â°üÀÇ ¾ö°ÝÇÑ °¡À̵å¶óÀÎÀº Ç×±Õ ¼ººÐÀÌ ÀÎü¿¡ ¾ÈÀüÇÏ°Ô »ç¿ëµÇ¾î Ç×±ÕÁ¦ ³»¼ºÀ» À¯¹ßÇÏ´Â ºÎÀÛ¿ëÀÌ ¹ß»ýÇÏÁö ¾Êµµ·Ï º¸ÀåÇÕ´Ï´Ù. Ç×±ÕÁ¦ ³»¼ºÀ» À¯¹ßÇÏ´Â ºÎÀÛ¿ëÀ» ÀÏÀ¸Å°Áö ¾Êµµ·Ï º¸ÀåÇÕ´Ï´Ù. ÀÌµé ±â°üÀº ¶ÇÇÑ ´Ù¾çÇÑ Á¦Ç°¿¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ÇÕ¼º Ç×±ÕÁ¦¿Í õ¿¬ Ç×±ÕÁ¦ÀÇ ¼öÁØÀ» ±ÔÁ¦ÇÏ¿© ¼ÒºñÀÚÀÇ ¾ÈÀüÀ» º¸ÀåÇÏ´Â µ¿½Ã¿¡ Á¦Á¶¾÷ü°¡ ÀÌ·¯ÇÑ ±âÁØ ¹üÀ§ ³»¿¡¼­ ±â¼ú Çõ½ÅÀ» Çϵµ·Ï Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ È¯°æ ¿À¿°ÀÇ À§ÇèÀ» ÁÙÀ̴ ģȯ°æ Ç×±ÕÁ¦°¡ ±ÔÁ¦ ´ë»ó¿¡ Æ÷ÇԵʿ¡ µû¶ó ȯ°æ ģȭÀûÀÌ°í ¹«ÇØÇÑ Ç×±ÕÁ¦¸¦ ã´Â ¿òÁ÷ÀÓµµ Ȱ¹ßÇØÁö°í ÀÖ½À´Ï´Ù.

Ç×±Õ ¼ººÐ¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

Ç×±Õ ¼ººÐ ½ÃÀåÀÇ ¼ºÀåÀº Àü¿°º´ÀÇ À¯Çà, À§»ý¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ´Ù¾çÇÑ »ê¾÷¿¡¼­ Ç×±Õ ÄÚÆÃÀÇ »ç¿ë Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ƯÈ÷ ÇコÄÉ¾î ºÐ¾ß¿¡¼­´Â º´¿ø³» °¨¿°(HAI) Áõ°¡·Î ÀÎÇØ ÀÇ·á±â±â, »óó °ü¸® Á¦Ç° ¹× º´¿ø ½Ã¼³¿¡¼­ Ç×±Õ Àç·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½Äǰ ¹× À½·á »ê¾÷¿¡¼­´Â ½ÄǰÀÇ ¾ÈÀü¼ºÀ» º¸ÀåÇϰí À¯Åë±âÇÑÀ» ¿¬ÀåÇϱâ À§ÇØ Ç×±Õ Æ÷ÀåÀ» äÅÃÇÏ´Â »ç·Ê°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °Ç°­ ÁöÇâÀûÀÎ ¶óÀÌÇÁ½ºÅ¸ÀÏ·Î ÀÎÇØ Ç×±Õ¼ºÀÌ ÀÖ´Â ÆÛ½º³ÎÄɾî Á¦Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼±È£µµµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹Ì»ý¹°ÀÇ ¼ºÀåÀ¸·Î ÀÎÇØ Á¦Ç°ÀÇ ³»±¸¼º°ú ¹Ì°üÀÌ ¼Õ»óµÉ ¼ö ÀÖ´Â °ÇÃà ¹× ¼¶À¯ »ê¾÷¿¡¼­ Ç×±Õ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 »õ·Î¿î ¿ëµµ¿Í ¼ºÀå ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(Ç×±ÕÁ¦, Ç×Áø±ÕÁ¦, Ç×Áø±ÕÁ¦, Ç×±â»ýÃæÁ¦, Ç×¹ÙÀÌ·¯½ºÁ¦), ÇüÅÂ(°ÇÁ¶ ÇüÅÂ, ¾×ü ÇüÅÂ), ÃÖÁ¾ ¿ëµµ(½ºÅ²Äɾî ÃÖÁ¾ ¿ëµµ, Çì¾îÄɾî ÃÖÁ¾ ¿ëµµ, ±¸°­ °ü¸® ÃÖÁ¾ ¿ëµµ, ¸ÞÀÌÅ©¾÷ ÃÖÁ¾ ¿ëµµ, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÁÖ¸ñ 46»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Antimicrobial Ingredients Market to Reach US$6.7 Billion by 2030

The global market for Antimicrobial Ingredients estimated at US$5.7 Billion in the year 2024, is expected to reach US$6.7 Billion by 2030, growing at a CAGR of 2.6% over the analysis period 2024-2030. Antibacterial Agent, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the Antifungal Agent segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 5.2% CAGR

The Antimicrobial Ingredients market in the U.S. is estimated at US$1.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 5.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.7% and 1.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Global Antimicrobial Ingredients Market - Key Trends & Drivers Summarized

Why Are Antimicrobial Ingredients Becoming Crucial for Consumer Products?

The global antimicrobial ingredients market is witnessing a significant rise, driven by increasing awareness regarding hygiene and health-conscious consumer behavior. These ingredients, which are used to inhibit the growth of harmful microorganisms, are being widely integrated into personal care products, pharmaceuticals, food packaging, and medical devices. This adoption is in response to growing concerns over infections, as well as the rising incidences of antimicrobial-resistant bacteria. Consumer demand for products that promise longer shelf life, safety, and cleanliness is pushing manufacturers to use antimicrobial compounds, especially in skin care, wound care, and food safety applications. This heightened awareness is reflected in the increasing preference for natural antimicrobial ingredients such as essential oils and plant extracts, which are perceived to be safer alternatives to synthetic chemicals.

How Is Technology Shaping the Future of Antimicrobial Ingredients?

Technological advancements in biotechnology and material science are transforming the landscape of antimicrobial ingredients. Nanotechnology, for instance, has enabled the development of more effective antimicrobial coatings, which provide prolonged protection and can be applied to a wide array of surfaces. Silver nanoparticles, for example, are gaining popularity in healthcare and consumer products due to their potent antimicrobial properties. The use of encapsulation technologies has also enhanced the efficiency of antimicrobial agents, enabling controlled release in applications such as wound dressings and food packaging. In addition, innovations in synthetic biology have allowed for the development of highly targeted antimicrobial peptides and enzymes that can neutralize specific pathogens without affecting beneficial microorganisms. This combination of new technologies is paving the way for more specialized and effective antimicrobial solutions across industries.

What Role Do Regulatory Standards Play in This Expanding Market?

Regulations and standards are playing a significant role in shaping the antimicrobial ingredients market, particularly in healthcare, food, and cosmetics industries. Stringent guidelines by regulatory bodies such as the FDA, European Medicines Agency, and EFSA ensure that antimicrobial ingredients are safe for human use and do not lead to adverse effects, such as contributing to antimicrobial resistance. These agencies also regulate the levels of synthetic and natural antimicrobials that can be used in various products, ensuring consumer safety while encouraging manufacturers to innovate within the boundaries of these standards. The push for environmentally friendly and non-toxic antimicrobial agents is also gaining momentum, as regulations favor eco-friendly alternatives that reduce the risk of environmental contamination.

What Is Fueling the Surge in Demand for Antimicrobial Ingredients?

The growth in the antimicrobial ingredients market is driven by several factors, including the increasing prevalence of infections, rising awareness about hygiene, and the growing use of antimicrobial coatings in various industries. The healthcare sector, in particular, is experiencing higher demand due to the rising number of hospital-acquired infections (HAIs), which has heightened the need for antimicrobial materials in medical devices, wound care products, and hospital equipment. Additionally, the food and beverage industry is increasingly adopting antimicrobial packaging to ensure food safety and extend shelf life. Consumer preferences for personal care products with antimicrobial properties, driven by health-conscious lifestyles, are also contributing to market growth. Furthermore, the demand for antimicrobial solutions in the construction and textile industries, where microbial growth can compromise product durability and aesthetics, is spurring new applications and opportunities for growth.

SCOPE OF STUDY:

The report analyzes the Antimicrobial Ingredients market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Antibacterial Agent, Antifungal Agent, Antiparasitic Agent, Antiviral Agent); Form (Dry Form, Liquid Form); End-Use (Skin Care End-Use, Hair Care End-Use, Oral Care End-Use, Make-Up End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 46 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â